$MEDP News

Medpace Holdings (MEDP) Rallies As A More Cautious Narrative Questions The Valuation

Baird Downgrades Medpace Holdings to Neutral, Raises Price Target to $547

Jefferies Downgrades Medpace Holdings to Hold, Raises Price Target to $515

Medpace (MEDP) Ascends While Market Falls: Some Facts to Note

CON or MEDP: Which Is the Better Value Stock Right Now?

Medpace (MEDP) Advances While Market Declines: Some Information for Investors

What Makes Medpace Holdings (MEDP) an Investment Bet?

Medpace (MEDP) Suffers a Larger Drop Than the General Market: Key Insights

Medpace Holdings, Inc. to Report Second Quarter 2026 Financial Results on July 22, 2026

Medpace (MEDP) Stock Weighing Modest Undervaluation Against Rich P/E And Mixed Momentum

CON vs. MEDP: Which Stock Is the Better Value Option?

Madison Small Cap Fund Increased Medpace Holdings (MEDP), Downplaying AI Fears

Why the Market Dipped But Medpace (MEDP) Gained Today

How Investors May Respond To Medpace (MEDP) Lawsuits And EVP Shift In Operating Leadership

Medpace (MEDP) Stock Slides as Market Rises: Facts to Know Before You Trade

2 Reasons to Watch MEDP and 1 to Stay Cautious

Medpace Class Actions Put Backlog Disclosures And Governance In Spotlight

Reflecting On Drug Development Inputs & Services Stocks’ Q1 Earnings: Medpace (NASDAQ:MEDP)

PACS vs. MEDP: Which Stock Is the Better Value Option?

Is Medpace Holdings, Inc. (MEDP) A Good Stock To Buy Now?